Abstract
Iron oxide and hafnium oxide nanocrystals are two of the few successful examples of inorganic nanocrystals used in a clinical setting. Although crucial to their application, their aqueous surface chemistry is not fully understood. The literature contains conflicting reports regarding the optimum binding group. To alleviate these inconsistencies, we set out to systematically investigate the interaction of carboxylic acids, phosphonic acids, and catechols to metal oxide nanocrystals in polar media. Using nuclear magnetic resonance spectroscopy and dynamic light scattering, we map out the pH-dependent binding affinity of the ligands toward hafnium oxide nanocrystals (an NMR-compatible model system). Carboxylic acids easily desorb in water from the surface and only provide limited colloidal stability from pH 2 to pH 6. Phosphonic acids, on the other hand, provide colloidal stability over a broader pH range but also feature a pH-dependent desorption from the surface. They are most suited for acidic to neutral environments (pH <8). Finally, nitrocatechol derivatives provide a tightly bound ligand shell and colloidal stability at physiological and basic pH (6–10). Whereas dynamically bound ligands (carboxylates and phosphonates) do not provide colloidal stability in phosphate-buffered saline, the tightly bound nitrocatechols provide long-term stability. We thus shed light on the complex ligand binding dynamics on metal oxide nanocrystals in aqueous environments. Finally, we provide a practical colloidal stability map, guiding researchers to rationally design ligands for their desired application.
Keywords: nanoparticle, catechol, carboxylic acid, phosphonic acid, hafnium oxide
Introduction
Colloidal nanocrystals (NCs) have been considered for a multitude of biomedical applications, such as bioimaging,1−3 drug delivery,4,5 photothermal therapy,6 and radiotherapy enhancement.7,8 These NCs are typically hybrid objects, consisting of an inorganic core capped with organic ligands. Inorganic ligands are more useful for devices.9 Ligands determine the interaction between NC and solvent and the stability of the nanocolloid.10 In the case of biomedical applications, controlling the NC surface chemistry is key as it will play a role in particle agglomeration, cellular uptake,11−13 protein repelling or adsorption,12,14,15 cytotoxicity,12,16 circulation time,15,17 and targeted approaches.18−20 Although surface chemistry is important for all types of NCs (chalcogenides, pnictides, halides, and metal NCs), not one solution fits all. For example, thiolates and thiols have a strong binding affinity to Au and CdSe NCs but interact poorly with metal oxide NCs.21
Metal oxide NCs have been particularly successful in nanomedicine. Three types of inorganic NCs have achieved clinical translation, and two of them are oxides: iron oxide and hafnium oxide.5 These particles are often first synthesized in nonpolar solvents and stabilized by surfactants (usually with a carboxylate or phosphonate headgroup and an aliphatic tail). Carboxylic acids (e.g., oleic acid) dissociate on the metal oxide surface, with carboxylates binding to surface metal sites and protons to surface oxygen atoms.22−24 This binding motif is written as NC(XX′) as both proton and carboxylate are X-type ligands.25 In nonpolar solvents, carboxylic acids are quantitatively exchanged by phosphonic acids in an X-for-X ligand exchange process.26 Indeed, phosphonic acids are very strong ligands for oxide surfaces.27,28 In contrast, catechol was found to be a rather weak ligand, only able to exchange a minor fraction of oleic acid.29 There is thus a clear order in binding strength in nonpolar solvents: catechol < carboxylic acid < phosphonic acid.
In aqueous (or other polar) environments, the order is less clear and further complicated by variable factors such as pH and salt concentration. For example, carboxylic acids are frequently used to stabilize metal oxide NCs in water.30−34 They are able to provide colloidal stability in static systems with no competing ligands but not in phosphate-buffered saline (PBS) or cell culture media.34 The binding affinity is significantly increased for multidentate carboxylate ligands such as polymers.35,36 In general, literature reports agree that carboxylic acids are the weakest ligands in water, weaker than phosphonic acids or catechols.37 The literature is, however, inconclusive as to whether phosphonic acids or catechols are the best ligand. For example, Guénin et al. concluded from Fourier transform infrared spectroscopy and density functional theory calculations that caffeic acid (a catechol) has a higher affinity for 9 nm iron oxide NCs than a bisphosphonate at physiological pH.38 In contrast, Zeininger et al. determined that phosphonic acids bind more strongly than catechols to TiO2 NCs in isopropyl alcohol at pH 7.39 Okada et al. came to the same conclusion on 9 nm iron oxide NCs by performing phase-transfer experiments using polar and nonpolar phosphonic acids and catechols.40 It is clear that, despite the common usage of phosphonic acids and catechols in metal oxide NC functionalization, there is no clear consensus on the relative binding affinity. Furthermore, a direct link between ligand binding equilibria and the final colloidal stability of the NCs is usually not made.
In this paper, we aim to unambiguously establish the binding affinity order and provide the correct surface chemistry for optimal application in nanomedicine. We chose HfO2 NCs as our model system for two reasons: (1) it is a relevant material in nanomedicine, and (2) it is compatible with solution nuclear magnetic resonance (NMR) spectroscopy. The latter has proven to be a very powerful tool to study nanocrystal surface chemistry,41−45 providing complementary information to solid-state NMR spectroscopy.44,47 Unfortunately, iron oxide NCs interfere with magnetic fields and cannot be studied in NMR. HfO2 NCs are thus an ideal starting point also because their surface chemistry has already been extensively studied in nonpolar solvents using NMR spectroscopy.22,23 First, we evaluate the ligand exchange of the native carboxylic acid ligands for phosphonic acid and catechol ligands, using 1H and 31P NMR spectroscopy. Importantly, we use the same polyethylene glycol ligand chain for all three binding groups, thus ensuring that we can directly compare the binding groups to each other. Next, we assess the influence of solvent (methanol vs water) and the pH on ligand binding. Furthermore, we used NMR and dynamic light scattering (DLS) to determine the colloidal stability provided by the different ligand types in aqueous and buffer environments and directly correlate this to ligand binding dynamics. Finally, we constructed a colloidal stability map, showing which binding group provides colloidal stability as a function of pH. This practical guide will help researchers in designing future surface chemistries.
Results
HfO2-MEEAA Model System
We synthesized HfO2 nanocrystals (NCs) from hafnium tert-butoxide and benzyl alcohol at 220 °C via an established solvothermal process (Figure 1A).48 The HfO2 surface was functionalized with 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (MEEAA; see Figure 1B) to stabilize the nanocrystals in toluene, and all unbound ligands were removed as described previously.45 The nanocrystals have a diameter of 2.64 ± 0.81 nm (μ ± 3σ) according to transmission electron microscopy (TEM) (Figure 1C) and possess the monoclinic (P21/c) crystal structure according to X-ray total scattering and pair distribution function (PDF) analysis (Figure S1). The 1H NMR spectrum of the nanocrystal dispersion in toluene-d8 only shows broadened resonances, assigned to bound ligands (Figure 1B). Indeed, spectral broadening is a typical attribute of bound ligands due to both homogeneous broadening (T2 relaxation) and heterogeneous broadening (imperfect solvation of the ligand shell).45
Figure 1.
(A) Solvothermal synthesis of HfO2 nanocrystals starting from 1 equiv of Hf(O-tBu)4 and 80 equiv of benzyl alcohol. (B) 1H NMR spectra (normal or diffusion filtered) of MEEAA-functionalized HfO2 NCs in different solvents. The α and β resonances belong to the residual hydroxyl and methyl groups of methanol, respectively. (C) TEM image of the synthesized HfO2 NCs. The NC diameter of the quasi-spherical NCs was calculated after measuring the surface area of at least 150 NCs and calculated the diameter as if it were a circle. A size distribution histogram and a zoomed-in image of a singular NC can be seen, respectively, in the bottom left and the top right corner.
The nanocrystals can also be dispersed in ethanol, methanol, and water and are thus an ideal starting point for our investigation into ligand binding behavior in polar solvents. In methanol-d4 (MeOD), the 1H NMR spectrum looks markedly different, with sharp signals superimposed on the broad resonances (Figure 1B). We assign the sharp signals to autodesorbed ligands, corroborated by the appearance of two sets of resonances in diffusion ordered spectroscopy (DOSY, Figure S2). DOSY allows one to separate (overlapping) NMR resonances according to their diffusion coefficient and thus separates the free ligands (quickly diffusing) from ligands bound to NCs (slowly diffusing).49 In Figure S2, the resonances with a diffusion coefficient D = 95 m2/s represent the bound ligands, and the resonances with D = 450 m2/s belong to the free ligands. We can selectively observe the bound ligands in a diffusion-filtered spectrum (Figure 1B), and upon close inspection, one observes that the bound MEEAA resonances in methanol-d4 are slightly sharper than the ones in toluene-d8, indicating a better solvation of the ligand shell in methanol.45 Given that all ligands were bound in toluene, we infer that the solvent clearly plays a role in the adsorption–desorption equilibrium, for instance, by changing the solubility of the ligand.50 Indeed, even a higher fraction of MEEAA ligands desorbs in water, D2O (see Figure S3), but the nanocrystals remain visibly stable in the pH range of 2–6. The NCs quickly precipitate at pH >6, and therefore, MEEAA is not a suitable ligand for many biomedical applications, which typically require stability at physiological conditions (pH 7.4).
Note that, aside from the main MEEAA signals, we also observed broad resonances with low intensity in the aromatic region of the 1H spectrum (Figure S4), assigned to benzoate ligands. Benzoic acid was previously identified as a side product of the nanocrystal synthesis and was found to be adsorbed on the nanocrystal surface.48 Functionalization of the surface with MEEAA after synthesis clearly did not remove all benzoate from the surface, and a small fraction remains present.
Competitive Binding of Phosphonic Acids
To evaluate the binding strength of phosphonic acids in methanol, we chose (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)phosphonic acid (PA-PEG) as a ligand with structure comparable to that of MEEAA (Figure 2A). In the 1H NMR spectrum, resonance 1 of PA-PEG has a chemical shift of 2.05 ppm, clearly separated from the MEEAA resonances, allowing us to selectively monitor the binding of PA-PEG (Figure 2B). As MEEAA has a methoxy group and PA-PEG does not, resonance f is used to gain selective information about the binding of MEEAA. The other resonances (2–6 and b–e) overlap.
Figure 2.
(A) Ligand exchange performed between MEEAA-functionalized NCs and PA-PEG. (B) 1H NMR reference spectra in MeOD of the free ligands as reference and the stepwise titration of MEEAA-functionalized NCs with PA-PEG, equivalents are with respect to the total amount of MEEAA present. (C) 31P NMR spectra (4096 scans) in MeOD for the stepwise titration of MEEAA-functionalized NCs with PA-PEG; broadened signals are indicative of NC binding. (D) Diffusion-filtered 1H NMR spectra of MEEAA-functionalized NCs in MeOD after addition of 1.3 equiv of PA-PEG. Signals arising from bound MEEAA are denoted in red, and signals arising from PA-PEG are denoted in striped blue. CNC = 1210 μmol L–1, corresponding to 34 mg NCs of this size in 0.5 mL of MeOD. Resonances denoted as * are unidentified impurities.
Starting from MEEAA-stabilized HfO2 nanocrystals in methanol-d4, we add PA-PEG in steps while monitoring the 1H NMR spectrum; see Figure 2B (full range spectra and additional titration points in Figure S5). During the titration, we observe the gradual appearance of a broad resonance around 2.2 ppm, assigned to resonance 1 of bound PA-PEG. Concomitantly, resonance f becomes more narrow (Figure 2B), indicating the removal of MEEAA from the nanocrystal surface. Within the aromatic region, we also observe desorption of benzoic acid (Figure S5). We conclude that PA-PEG is effectively displacing MEEAA and benzoic acid. Given the absence of free phosphonic acid, the exchange is quantitative for most of the titration. After addition of 1.3 equiv of phosphonic acid, sharp signals appear in the same region, indicating that there is now free PA-PEG present. The same conclusions are drawn from the 31P spectra, as well (Figure 2C), where first a broad signal grows in intensity and a sharp 31P signal appears after adding more than 1 equiv. Interestingly, the bound PA-PEG resonance still increases slightly in intensity between 1.3 and 1.6 equiv. We infer that the last part of the exchange does not proceed quantitatively, and the remaining carboxylate ligands are more difficult to remove. This observation implies that the binding affinity (ΔGads) is not a single, fixed quantity for all MEEAA ligands but rather a distribution, as has been previously shown for CdSe nanocrystals.51
Unfortunately, the NMR spectra feature a lot of spectral overlap, with superimposed signals of free and bound ligands. At the end of the titration, the resonances of free ligands dominate the spectrum. To gain more insight into the composition of the ligand shell at that point, we turn to the diffusion-filtered spectrum (Figure 2D, full range in Figure S6). Whereas resonances 2–6 overlap with resonances b–e, the clear presence of resonance f indicates the presence of residual MEEAA on the surface. Based on the diffusion-filtered profile of bound MEEAA (Figure S4), we assigned the part of the spectrum belonging to MEEAA as the red shaded area. The blue striped area is assigned to PA-PEG. There is also still benzoate present on the surface according to the regular 1H spectrum, but the signal-to-noise of these resonances was too low in the diffusion-filtered spectrum due to their faster T2 relaxation (because of rigidity and proximity to the surface). The above results thus confirm that the exchange between the carboxylate ligands and PA-PEG does not go to completion in methanol. This conclusion stands in contrast to the relative binding affinities of fatty acids and alkylphosphonic acids in nonpolar solvents, where phosphonic acids quantitatively replace carboxylic acids in a 1:1 stoichiometry.26,52,53
The autodesorption of MEEAA in methanol already indicated that the ligand solubility can change the binding affinity. Indeed, ligand binding is an equilibrium process, governed by the chemical potential of each species:
![]() |
1 |
Therefore, this adsorption–desorption equilibrium is dependent on the chemical potential of the free ligand (and thus the solubility).50 To further explore this concept in practice, we designed a ligand shell architecture that would mimic a micelle, having both a hydrophobic and a hydrophilic segment. To this end, we chose the ligand (6-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]hexyl)phosphonic acid (PA-hex-PEG); see Figure 3. We hypothesized that this ligand would more readily self-assemble on the nanocrystal surface as the hydrophobic region decreases the solubility in polar solvents. Using PA-hex-PEG, we performed the same titration experiment as before. The results are generally quite similar, showing the exchange of carboxylate ligands for PA-hex-PEG (Figure S7 and Figure S8). However, this time, most benzoate ligands are removed by PA-hex-PEG (although not completely) and hardly any MEEAA resonances are detectable in the diffusion-filtered spectrum (Figure 3). We conclude that, indeed, the competitive binding can be manipulated by changing the ligand solubility. Interestingly, benzoic acid appears to have a binding affinity higher than that of MEEAA, which could be ascribed to both its higher acidity and its lower solubility in methanol.
Figure 3.
Diffusion-filtered 1H NMR spectrum of the NC suspension in MeOD with 1.3 equiv of PA-hex-PEG added.
Purification and Transfer to Water of Phosphonate-Capped Nanocrystals
With our final goal in mind of providing a stable surface chemistry for biomedical applications, we sought to purify our dispersions and disperse them in aqueous media. Precipitation–redispersion cycles are the most common way of purifying nanocrystals. However, the great versatility of the ethylene glycol segment provides colloidal stability in a broad range of solvents, and nonsolvents, such as hexane, do not mix well with methanol. Therefore, we choose to purify our dispersion using spin filtration, a form of ultrafiltration. The technique is based on semipermeable membranes (like dialysis), where small molecules can pass through the pores but large nanocrystals cannot. By performing the separation in a centrifuge, purification is expedited. First, the nanocrystal suspension is placed in the spin filter and further diluted with pure methanol. Figure S9 shows that dilution does not induce ligand desorption. After filtration, a concentrated dispersion of nanocrystals is retrieved. The purification is successful, as shown by the removal of almost all unbound species after three purification cycles (Figure S10). A comparison of the diffusion-filtered spectra before and after spin filtration shows a perfect match, proving that the purification did not change the ligand shell composition (Figure S10). Interesting differences between PA-PEG and PA-hex-PEG were observed when the solvent composition gradually changed from pure methanol-d4 to D2O (Figure 4). Whereas PA-PEG gradually desorbs from the surface when increasing the water content, PA-hex-PEG remains tightly bound. This further underscores our hypothesis that PA-hex-PEG behaves as a micelle mimic, avoiding contact of the hydrophobic segment with water. By binding the nanocrystal surface, the PA-hex-PEG ligand creates a hydrophobic inner shell with alkyl–alkyl interactions and a hydrophilic outer shell with ethylene glycol moieties as the hydrogen bond acceptor for water molecules. PA-PEG, on the other hand, is highly water-soluble, and thus the affinity for the hafnium oxide surface decreases upon increasing the water content.
Figure 4.
(A,B) 31P NMR spectra of PA-PEG- and PA-hex-PEG-functionalized NCs at different D2O volume %. (C) Free ligand fraction for PA-PEG and PA-hex-PEG at different D2O volume %, determined by peak deconvolution.
Synthesis and Binding of Catechols
We synthesized N-(4,5-dihydroxy-2-nitrophenethyl)-2-(2-(2-methoxyethoxy)ethoxy)acetamide (nitrodopamine-mPEG); see Scheme 1. We opted for a nitrocatechol instead of an unsubstituted catechol because the nitro group decreases the catechol pKa values and improves the oxidative stability of the catechol. Nitrodopamine was also shown to provide colloidal stability to iron oxide nanoparticles better than unsubstituted dopamine.54 Starting from dopamine hydrochloride, a one-step nitration reaction results in the formation of nitrodopamine hemisulfate. Separately, MEEAA was converted in an activated N-hydroxysuccinimide ester (MEEAA-NHS) using N,N′-dicyclohexylcarbodiimide (DCC), N-hydroxysuccinimide (NHS), and 4-dimethylaminopyridine (DMAP). The coupling between nitrodopamine hemisulfate and MEEAA-NHS was performed using N-methylmorpholine (NMM) acting as a non-nucleophilic base. The final nitrodopamine-mPEG ligand was purified using preparative high-performance liquid chromatography (HPLC) and fully characterized with electrospray ionization/high-resolution mass spectrometry (ESI-HRMS) and NMR spectroscopy (see Supporting Information).
Scheme 1. (A) Synthesis of Nitrodopamine Hemisulfate, (B) Synthesis of MEEAA-NHS, and (C) Synthesis of Nitrodopamine-mPEG,
Reagents and conditions: (i) NaNO2, 20% H2SO4, H2O, 0 °C to RT, 12 h, 50%; (ii) NHS, DCC, DMAP, dry THF, 0 °C to RT, 12 h, 83%; (iii) NMM, dry DMF, RT, 48 h, 75%.
When we performed a similar competitive binding experiment as before (addition of nitrodopamine-mPEG to MEEAA-capped HfO2 nanocrystals in methanol-d4), we found that 1 equiv of nitrodopamine-mPEG was unable to effectively compete for the nanocrystal surface; even at merely 0.4 equiv of catechol, freely diffusing nitrodopamine-mPEG signals could be observed (Figure S11). Such a low binding affinity was highly unexpected, given many reports of successful surface functionalization with catechols.40,54,57−61 However, in these reports, water or biological buffers were used as the solvent. Therefore, we designed a competitive binding experiment directly in water. Fortunately, MEEAA-stabilized HfO2 nanocrystals are stable in D2O, even though a significant portion of MEEAA is desorbed (Figure S3). The addition of 1 equiv nitrodopamine-mPEG, without adjusting the pH, results in a turbid suspension with pH at 2. When the pH is adjusted to pH 5, a stable suspension is obtained. To allow for a systematic, gradual addition of nitrodopamine-mPEG, we prepared a stock solution of nitrodopamine-mPEG with 2 equiv of NaOD to doubly deprotonate the catechol. Addition of the base changes the color of the solution from light yellow to a deep burgundy (Figure S12). We added this stock solution to a suspension of MEEAA-stabilized HfO2 in steps of 0.5 equiv and recorded both standard 1H NMR and diffusion-filtered NMR spectra. After addition of 0.5 equiv, we did not observe any sharp signals belonging to nitrodopamine-mPEG, whereas we did observe desorbed benzoic acid and desorbed MEEAA (Figure S13). In the diffusion-filtered spectrum, we also see a clear change. In the aromatic region, the broad signals of benzoate are replaced by the broad signals of nitrodopamine-mPEG. The peak shape of the region at 3–4 ppm is also altered (Figure S14). The exchange continues as more nitrodopamine-mPEG is added, and upon addition of 1.5 equiv, sharp (unbound) nitrodopamine-mPEG signals are detected (Figure S13). The suspension remains stable despite the pH being 10.3 at this point in the titration, providing further evidence that the ligand exchange was successful as MEEAA-stabilized nanocrystals would precipitate at pH >6. We conclude that nitrodopamine-mPEG can quantitatively displace MEEAA from the nanocrystal surface if the pH is >5.
The NCs were again purified using multiple cycles of spin filtration, using Milli-Q water as solvent, until the filtrate was nearly colorless (Figure S15). The concentrate was evaporated and redispersed in D2O, and the pH was adjusted to 7.4. Figure 5B contains a regular 1H NMR spectrum of the purified suspension; the purity of the sample is striking, and only broadened resonances pertaining to nitrodopamine-mPEG are observed. Based on a thermogravimetric analysis of mass loss of 23%, we calculated a nitrodopamine-mPEG ligand density of 2.14 nm–2 at the nanocrystal surface. We conclude that nitrodopamine-mPEG forms a tightly bound ligand shell on the nanocrystals at physiological pH with no signs of desorption.
Figure 5.
(A) Ligand exchange performed between MEEAA-functionalized NCs and nitrodopamine-mPEG. (B) 1H NMR spectra before and after the ligand exchange titration performed in D2O with nitrodopamine-mPEG. First, 1.5 equiv of nitrodopamine-mPEG was added, and the pH was kept above 5 at all times during addition. The purified nitrodopamine-functionalized NC spectrum was measured at pH 7.4. The reference spectrum of nitrodopamine-mPEG is also shown. CNC = 128 μmol L–1, corresponding to 14.4 mg NCs of this size in 2 mL of D2O.
pH Dependence of Ligand Binding
As it is obvious that pH plays a crucial role in ligand binding in aqueous environments, we systematically varied the pH from 3 to 10 and used 1H NMR, 31P NMR, and DLS to assess the ligand binding and colloidal stability (Figure 6). From NMR, we extract the bound ligand fraction for the phosphonic acid ligands via peak deconvolution of the 31P resonances and for nitrodopamine-mPEG via peak deconvolution of the aromatic 1H resonances (Tables S3–S5). From DLS measurements, we obtained the Z-average value and the zeta-potential. The Z-average value is a single value describing the average particle size and is most sensitive to agglomeration. The zeta-potential indicates the degree of electrostatic repulsion between the nanocrystals (zeta-potential values above +25 mV or below −25 mV indicate stable suspensions). From Figure 6, we clearly observe that the bound ligand fraction decreases with increasing pH for both PA-PEG and PA-hex-PEG. Taking the pKa values of ethyl phosphonic acid (pKa1 = 2.43 ; pKa2 = 8.05) as a reference, it is striking that the bound ligand fraction decreases most steeply around pKa2. We infer that the second deprotonation of the phosphonic acid causes ligand–ligand repulsion in the ligand shell and increases the solubility of the ligand in water. Both effects lead to a reduced bound ligand fraction. Not surprisingly, the loss of ligands has a detrimental effect on the colloidal stability, and the Z-average increases significantly for pH > pKa2. Overall, PA-hex-PEG performs slightly better than PA-PEG, but the difference is small. Most likely, the double anionic phosphonate compensates for the short hydrophobic segment.
Figure 6.
Effect of pH on ligand binding and stability in water for purified NCs functionalized with PA-PEG, PA-hex-PEG, and nitrodopamine-mPEG. (A) Bound ligand fraction in D2O based on NMR peak deconvolution at different pH values. (B) Z-average value of NCs in DLS at different pH values. (C) Zeta-potential of the NCs at different pH values. All measurements were performed at constant ionic strength (0.01 mol L–1 NaCl) at 25 °C.
One might expect complete loss of colloidal stability upon ligand desorption. However, no visual turbidity was observed in the samples, and the Z-average remains below 100 nm. Note that the zeta-potential drops below −25 mV at pH >8. While steric stabilization is lost with progressing ligand desorption, electrostatic stabilization takes over, preventing the NCs from fully destabilizing. The negative charge could originate from residual-bound, double deprotonated phosphonates, or more likely from hydroxide adsorption on the nanocrystal surface. Indeed, in water, there are multiple adsorption–desorption equilibria present simultaneously.
![]() |
2 |
![]() |
3 |
![]() |
4 |
In addition to these adsorption–desorption equilibria, there are also the acid–base equilibria, resulting in a highly complex pH dependence of the system.
According to Figure 6, the phosphonic acids keep the nanocrystals stable between pH 3 and pH 8 in a static system. However, in a dynamic biological environment (e.g., a blood vessel), many competing ligands are present and desorbed ligands are quickly removed. The equilibrium will adjust and thus ligands will continuously desorb from the surface, eventually causing loss of colloidal stability. Despite an acceptable Z-average value at physiological pH, this dynamic behavior could explain why single phosphonate ligands are not necessarily successful at fully preventing aggregation in physiological media.62−66
Interestingly, nitrodopamine-mPEG has almost the complete opposite behavior, unable to provide stable colloidal dispersions under acidic conditions with a very sharp transition around pH 5. This is evidenced by the steep increase in the Z-average (Figure 6). Between pH 5 and pH 10, all nitrodopamine-mPEG ligands remain bound, and only at pH 11, there is a slight decrease in the bound fraction from 100 to 97% (full range 1H NMR spectra in Figure S16). This translates to an excellent colloidal stability in the pH range of 5–11. We conclude that for aqueous applications at physiological pH, nitrodopamine-mPEG outperforms both PA-PEG and PA-hex-PEG. For aqueous applications at acidic pH, on the other hand, the phosphonic acid ligands are better suited. To test if there would also be a temperature dependence on the binding dynamics of the functionalized NC systems, we performed variable-temperature NMR measurements in D2O (pH 7.4) at 25, 37, and 60 °C (Figure S17). 1H NMR spectra showed no change in ligand adsorption/desorption equilibria for both phosphonic acids and nitrodopamine-mPEG, leading us to tentatively conclude that the results from the pH titrations would also translate to physiological temperature.
To illustrate the complementary behavior of phosphonic acids and catechols, we performed a competitive exchange reaction on purified nitrodopamine-mPEG NCs in D2O. One equivalent of PA-PEG was added, compared to the original amount added to functionalize the NCs with nitrodopamine-mPEG, and NMR measurements were performed at different pH values (Figure S18). Figure S18 clearly shows that, at acidic pH values, a partial exchange with PA-PEG occurs, evidenced by the appearance of sharp nitrodopamine-mPEG signals in the aromatic region and methylene triplet around 3 ppm. The nitrodopamine-mPEG NC suspension, which normally would fully destabilize below pH 5, remained colloidally stable at pH 2.22 due to the now mixed catechol–phosphonate ligand shell. The exchange equilibrium mostly shifts back toward nitrodopamine-mPEG as the pH moves toward neutral and basic values.
Stability in Phosphate-Buffered Saline
Finally, we assessed the stability of NCs functionalized with PA-PEG, PA-hex-PEG, and nitrodopamine-mPEG in PBS. Stability in PBS is an important prerequisite for biomedical applications, as many in vivo experiments inject the desired drug or contrast agent in saline solution or in PBS. A standard 1× PBS buffer contains 137 mmol L–1 NaCl, 2.7 mmol L–1 KCl, 10 mmol L–1 Na2HPO4, and 1.8 mmol L–1 KH2PO4. When the concentrations are half or double, these buffers are referred to as 0.5× PBS and 2× PBS, respectively. It is clear that PBS contains relatively high salt concentrations and phosphate ions (which will compete for the surface) and thus provides a real test for the stability of our functionalized nanocrystals. First, we varied the PBS concentration and immediately measured the Z-average via DLS (Figure 7A). Up to 1.5× PBS, all ligands keep the nanocrystals colloidally stable. As expected, PA-PEG is the weakest ligand and cannot prevent the start of nanocrystal aggregation in 2× PBS solutions. Second, the stability of all functionalized NCs was monitored over time in 2× PBS (Figure 7B). Clearly, PA-PEG-functionalized nanocrystals agglomerate quickly and visually precipitate after several hours. The colloidal stability of PA-hex-PEG-functionalized nanocrystals steadily decreases over 24 h, before completely agglomerating. Only nitrodopamine-mPEG-functionalized nanocrystals remain perfectly stable. There is no sign of aggregation over the course of 48 h, and the suspension also remains visually clear for at least 1 month.
Figure 7.
Stability of functionalized NCs in PBS at pH 7.4 and 25 °C. (A) Colloidal stability of functionalized nanocrystals measured using DLS Z-average values at different PBS concentrations. (B) Stability of functionalized NCs in 2× PBS over time.
Discussion
The above results make clear that surface chemistry becomes much more complex when moving from nonpolar to polar (e.g., aqueous) solvents. In nonpolar solvents, charged ligands or nanocrystals are thermodynamically unstable, leading to a limited set of binding motifs and clear ligand exchange rules.25 For example, autodesorption of oleate (deprotonated oleic acid) does not occur in toluene. For the binding motif of PbS(PbX2), removal of the entire Lewis acid PbX2 has been observed in chloroform or coordinating solvents like THF.67 Likewise, for HfO2(H,OOCR), desorption of oleic acid is possible by recombination of the carboxylate and proton.22 However, these restrictions disappear in polar solvents where charges are stabilized, and the proton and carboxylate have independent adsorption/desorption equilibria; see also eqs 2–4.
From the above data, we constructed a colloidal stability map, indicating which ligands provide colloidal stability in specific pH ranges (see Figure 8). It is interesting to correlate this stability map to the pKa values of the ligands, which we experimentally determined via acid–base titrations (Figure S19). The pKa values of PA-PEG are pKa1 = 2.65 ± 0.01 and pKa2 = 7.56 ± 0.01, and those of PA-hex-PEG are pKa1 = 2.99 ± 0.02 and pKa2 = 8.33 ± 0.01. At pH 3 (where the particles are stable), we calculate using eq 5 that approximately 70% of PA-PEG is monodeprotonated. One can assume that the phosphonate will bind in this form to the nanocrystal surface.
![]() |
5 |
For pH >8.5 (above pKa2), the bound ligand fraction decreases quickly and the particles start to aggregate (Figure 6). The double deprotonation of the ligand has two consequences; (1) the ligand becomes more soluble in water, and (2) electrostatic ligand–ligand repulsion appears, instead of the stabilizing hydrogen bonding. Both effects promote ligand desorption. In addition, the isoelectric point of HfO2 occurs at pH 8,68 rendering the surface negatively charged at pH >8, thus further decreasing the binding affinity of the negatively charged phosphonate ligand. Esarey et al. observed a similar phenomenon when studying the binding constant of a phosphonate-anchored rubidium complex on anatase TiO2 surfaces under varying pH conditions.69
Figure 8.
Colloidal stability map for metal oxide nanocrystals functionalized with carboxylic acids, phosphonic acids, and catechols. In this concrete example, we used HfO2 as the NC model system with its respective isoelectric point, MEEAA as the carboxylic acid, PA-PEG as the phosphonic acid, and nitrodopamine-mPEG as the catechol. The map colors should be interpreted as follows: green, excellent colloidal stability; striped green, high fraction of bound ligands but not perfect, use in a static system; orange, low bound ligand fraction, use in a static system without competition; red, nanocrystal aggregation/precipitation, do not use.
A similar reasoning applies to the case of nitrodopamine-mPEG (pKa1 = 7.13 ± 0.01; pKa2 = 10.8 ± 0.01). At pH = 5 (where the particles are unstable), we calculate that approximately 99% of the ligand is fully protonated and can thus only interact with the surface via weak hydrogen bonds.70 With increasing pH, a progressively higher fraction of nitrodopamine-mPEG is monodeprotonated, and is able to coordinate to the surface metal sites. It also provides an additional hydrogen bond to further stabilize the bound state. This is confirmed by comparing the UV–vis spectra of nitrodopamine-mPEG bound to HfO2 NCs with the reference spectra of the free ligand (see Figure 9 and Figure S20). For 5 < pH < 11, we find the monodeprotonated species. At pH >11, we see again the appearance of free ligands in NMR (Figure S16) and the double deprotonated species in UV–vis (Figure S20). For the reasons mentioned above, the double deprotonated species has a low binding affinity for the surface. In addition, the catechol becomes sensitive to oxidation at high pH. Finally, carboxylic acids can only be monodeprotonated and we observe that NCs functionalized with MEEAA (pKa = 3.61 ± 0.03) gradually lose colloidal stability above pH 3.5 before fully precipitating above pH 6 (Figures S21 and S22). We hypothesize that they are less stable than phosphonates and catechols due to the lack of ligand–ligand hydrogen bonding.
Figure 9.
UV–vis spectra of purified nitrodopamine-mPEG-functionalized NCs at different pH values in H2O.
The stability experiments in buffer solution point to an additional variable: competitive ligands. In phosphate-buffered saline, a high concentration of phosphate is present, which competes for the surface but does not provide steric stabilization. Since the phosphonic acids (PA-PEG and PA-hex-PEG) desorb at pH 7.4 (25% desorbed; see Figure 6), they are in equilibrium and can thus be slowly displaced over time. The nitrodopamine-mPEG is tightly bound (0% desorbed) and is not being displaced by phosphonic acid, judging from our competition experiments (Figure S18), hence the high stability of the particles capped with nitrodopamine-mPEG.
The above discussion shows that, in aqueous media, surface chemistry is a complex interplay between multiple factors. There is the pH-dependent charge of the surface, the pH-dependent deprotonation of the ligand, and competition by phosphate in buffer solution. Slight modifications to the ligand structure can alter the solubility of the ligands and thus the binding affinity. The binding group remains, however, the most important descriptor for the stability map, a conclusion supported by the relatively small differences between PA-PEG and PA-hex-PEG in their pH-dependent desorption from the surface. The colloidal stability map can thus be generalized to other carboxylate, phosphonate, and catecholate ligands. The pKa values of the ligands used here are quite close to reported pKa values for acetic acid (pKa = 4.75), ethylphosphonic acid (pKa1 = 2.43; pKa2 = 8.05), and nitrodopamine (pKa1 = 6.6; pKa2 = 11).71 For optimal accuracy, it is recommended to insert the actual pKa values for the ligands of interest, as the stable pH ranges will shift together with the pKa(s) of the ligand. For other oxide nanocrystals (e.g., TiO2 or Fe2O3), the corresponding isoelectric point needs to be used. Having thus the pKa(s) of the ligands available and the isoelectric point of the nanocrystals, one can now use the colloidal stability map (Figure 8) to start predicting which ligands will provide colloidal stability at a particular pH. A word of caution is warranted. Small structural variations in the ligand will have little influence on the predictions of the stability map, but significant structural variations, such as a high steric bulk, could have adverse effects on the binding affinity.
Conclusion
We have mapped out the binding affinity of the three most important ligands for metal oxide nanocrystal surface functionalization. By performing an in-depth surface chemistry and stability study, we found that ligand dynamics become much more complex when moving from nonpolar to polar solvents. In water, the pH influences the ligand solubility through deprotonation of the binding group. Carboxylic acids are weakly binding anchors in both nonpolar and polar environments and can be easily displaced by competitive ligands. Phosphonic acids are strongly bound ligands in MeOH but desorb in aqueous media, the extent of which is dependent on the pH. They are mostly suited to stabilize nanocrystals in acidic environments. Finally, nitrocatechol derivatives provide a tightly bound ligand shell and excellent stability at physiological and basic pH. They are superior at stabilizing metal oxide nanocrystals in phosphate-buffered saline solutions but cannot be used in acidic environments. We have summarized our results in a convenient colloidal stability map that can be generalized to other oxides and ligands, provided the isoelectric points and pKa values are available. This tool will allow researchers to rationally choose nanocrystal functionalization strategies for their desired applications in polar or aqueous environments.
Experimental Methods
Materials
(6-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}hexyl)phosphonic acid and (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)phosphonic acid were purchased from SiKÉMIA. N-Hydroxysuccinimide (≥98%) and dopamine hydrochloride (≥99%) were purchased from Acros Organics. 2-[2-(2-Methoxyethoxy)ethoxy]acetic acid (>95.0%) was purchased from TCI Chemicals. Hafnium(IV) tert-butoxide (99.99%), N,N′-dicyclohexylcarbodiimide (99%), 4-(dimethylamino)pyridine (≥99%), 4-methylmorpholine (99%), sodium nitrite (≥99.0%), and solvents used for synthesis were purchased from Sigma-Aldrich. All purchased chemicals were used without further purification. All deuterated solvents were purchased from Sigma-Aldrich or Eurisotop.
Synthesis of MEEAA-NHS
This procedure was adapted from Meissler et al.:56 4 mmol (0.7128 g) 2-[2-(2-methoxyethoxy)ethoxy]acetic acid and 4.2 mmol (0.4828 g) N-hydroxysuccinimide were dissolved in 8 mL of dry THF in a predried vial and cooled to 0 °C. Then 4.2 mmol (0.866 g) N,N′-dicyclohexylcarbodiimide was dissolved in a separate predried vial in 4 mL of THF and added dropwise to the first mixture by performing an air-free transfer. The mixture was stirred for 15 min at 0 °C, after which 0.2 mmol (0.024 g) catalytic 4-dimethylaminopyridine was added. The mixture was stirred overnight at room temperature, resulting in a white turbid mixture. The turbid solution was filtered over a por 4 fritted glass filter, and the white precipitate was washed once with 10 mL of THF to collect the remaining product. After solvent removal of the filtrate using a rotary evaporator, the viscous liquid was dissolved in a minimum amount of DCM and transferred to a extraction funnel via a 0.2 μm syringe filter, and the organic phase was then diluted to a volume of 12 mL using DCM. The organic phase was extracted four times with 12 mL of Milli-Q (MQ) water and two more times with 12 mL of brine. The organic phase was dried over MgSO4 and dried using a rotary evaporator. Product was collected as a colorless to light yellow viscous liquid with 83% yield. 1H NMR (500 MHz, CDCl3): δ 4.5 (s, 2H), 3.8–3.76 (m, 2H), 3.7–3.66 (m, 2H), 3.65–3.6 (m, 2H), 3.55–3.51 (m, 2H), 3.36 (s, 3H), 2.82 (s, 4H). 13C NMR (500 MHz, CDCl3): δ 168.73 (s), 166.02 (s), 77.24 (s), 71.91 (s), 71.37 (s), 70.607 (s), 70.602 (s), 66.55 (s), 59.06 (s), 25.58 (s). HRMS 275.26 calcd for [M], 292.9 [M + NH4]+ found.
Synthesis of Nitrodopamine Hemisulfate
The procedure was adapted from Napolitano et al.:55 8.753 mmol (1.66 g) dopamine hydrochloride and 35.219 mmol (2.43 g) NaNO2 were dissolved in 100 mL of MQ water and cooled in an ice bath. Then 8.33 mL of precooled 20% H2SO4 was added dropwise to the mixture under heavy stirring; during addition, the mixture turned turbid yellow with the formation of brown gases. The mixture was removed from the ice bath and was allowed to stir 12 h at room temperature. The resulting turbid yellow solution was cooled again in an ice bath, followed by collection of the solid via suction filtration using a por 4 fritted glass filter. Next, the solid was washed two times with 50 mL of ice-cold MQ water, one time with 50 mL of ice-cold absolute ethanol, and two times with 50 mL of ice-cold diethyl ether. The yellow powder was collected and dried overnight under vacuum, final yield was 50%. 1H NMR (500 MHz, DMSO-d6): δ 7.46 (s, 1H), 6.73 (s, 1H), 3.12–2.99 (m, 4H). 13C NMR (500 MHz, DMSO-d6): δ 156.49 (s), 145.24 (s), 136.31 (s), 127.32 (s), 111.14 (s), 39.15 (s), 31.56 (s). HRMS 296.25 calcd for [M], 197.00 [M – H2SO4 – H]− found.
Synthesis of Nitrodopamine-mPEG
The procedure was inspired by Amstad et al.:54 1.784 mmol (491 mg) MEEAA-NHS and 2.854 mmol (846 mg) nitrodopamine hemisulfate were dissolved in 25 mL of dry DMF in a predried flask, resulting in a dark orange solution. The flask was sealed, flushed with argon, and cooled in an ice bath. Then 785 μL of N-methylmorpholine was added dropwise to the mixture using air-free technique; after approximately 15 min of stirring, the solution became turbid. The mixture was allowed to stir 48 h at room temperature, followed by evaporation overnight under vacuum at 40 °C to remove DMF, yielding a dark brown liquid. Next, 40 mL of 1 M HCl was added to the crude and extracted three times with 40 mL of CHCl3; a dark brown solid is formed during the process at the liquid interface, and care was taken to not allow this to enter the organic phase. The organic phase was extracted with 50 mL of brine, dried with Na2SO4, and evaporated using rotary evaporation. The resulting solid was purified with preparative HPLC using a gradient from solvent A (MQ water containing 0.1% TFA) to solvent B (ACN containing 0.1% TFA), and after being freeze-dried, the final product was isolated as a fluffy white-yellow solid with 75% yield. 1H NMR (500 MHz, MeOD): δ 7.54 (s, 1H), 6.7 (s, 1H), 3.93 (s, 2H), 3.62 (s, 4H), 3.61–3.58 (m, 2H), 3.57–3.5 (m, 4H), 3.35 (s, 3H), 3.07 (t, 2H, J = 6.68 Hz). 13C NMR (500 MHz, MeOD): δ 173.05 (s), 152.4 (s), 145.53 (s), 141.06 (s), 129.39 (s), 119.61 (s), 113.56 (s), 72.97 (s), 72.07 (s), 71.4 (s), 71.39 (s), 71.24 (s), 59.21 (s), 40.47 (s), 34.14 (s). HRMS 358.35 calcd for [M], 357.35 [M – H]− found.
Synthesis of Hafnium Oxide Nanocrystals
The NCs were synthesized from hafnium(IV) tert-butoxide (5.47 mmol, 2.58 g, 2.21 mL) and anhydrous benzyl alcohol (45.6 mL) according to Lauria et al.48 After the synthesis, the nanocrystals were collected by adding diethyl ether (19 mL) to the reaction mixture and centrifugation (5000 rcf, 5 min) in plastic centrifuge tubes. The sediment was washed three times with diethyl ether (19 mL). For functionalization with 2-(2-(2-methoxyethoxy)ethoxy)acetic acid, the sediment was first dispersed in 19 mL of toluene, resulting in a milky white turbid liquid. Then 381 μL of 2-(2-(2-methoxyethoxy)ethoxy)acetic acid (0.328 g; 1.82 mmol) was added followed by 30 min of sonication, resulting in a transparent suspension with a few insolubles present. The insolubles were removed by centrifugation (5000 rcf, 5 min), and the clear top layer was transferred to new plastic centrifuge tubes. NCs were precipitated by addition of 1:2 volume of hexane (mixture of isomers); after centrifugation (5000 rcf, 5 min), the organic top phase was removed, and the NCs were resuspended in toluene. This purification step was repeated three more times before final resuspension in toluene, and the final NC yield was 70%. The purified NC suspension in toluene remains stable for at least 1 year. The dispersion in toluene can be dried and dispersed in ethanol. From ethanol, the dispersion can be dried again and resuspended in MeOH, and from MeOH, the dispersion can be dried again and resuspended in H2O.
Acknowledgments
The authors gratefully acknowledge the Research Foundation–Flanders (Project No. 1SA4221N and 1S11721N) and the SNSF NCCR Molecular Systems Engineering (Project No. 182895) for funding. The authors thank Prof. Daniel Häussinger for providing valuable advice and essential technical support with respect to advanced NMR measurements. The authors also thank Katrien Haustraete for TEM measurements, Tine Veevaete for assisting with automatic pH titrations, and Mahsa Parvizian for LC-MS measurements. We acknowledge DESY (Hamburg, Germany), a member of the Helmholtz Association HGF, for the provision of experimental facilities. Parts of this research were carried out at PETRA III and we would like to thank Dr. Soham Banerjee and Dr. Ann-Christin Dippel for assistance in using beamline P21.1.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacsau.1c00565.
Additional experimental methods, NMR spectra of titrations and synthesized compounds, PDF analysis, peak deconvolutions, UV–vis spectra of nitrodopamine-mPEG, DLS data of carboxylate-capped nanocrystals; acid-base titrations for all ligands (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- Smith B. R.; Gambhir S. S. Nanomaterials for In Vivo Imaging. Chem. Rev. 2017, 117 (3), 901–986. 10.1021/acs.chemrev.6b00073. [DOI] [PubMed] [Google Scholar]
- Na H. B.; Song I. C.; Hyeon T. Inorganic Nanoparticles for MRI Contrast Agents. Adv. Mater. 2009, 21 (21), 2133–2148. 10.1002/adma.200802366. [DOI] [Google Scholar]
- Dong H.; Du S.-R.; Zheng X.-Y.; Lyu G.-M.; Sun L.-D.; Li L.-D.; Zhang P.-Z.; Zhang C.; Yan C.-H. Lanthanide Nanoparticles: From Design toward Bioimaging and Therapy. Chem. Rev. 2015, 115 (19), 10725–10815. 10.1021/acs.chemrev.5b00091. [DOI] [PubMed] [Google Scholar]
- Chen G.; Roy I.; Yang C.; Prasad P. N. Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy. Chem. Rev. 2016, 116 (5), 2826–2885. 10.1021/acs.chemrev.5b00148. [DOI] [PubMed] [Google Scholar]
- Min Y.; Caster J. M.; Eblan M. J.; Wang A. Z. Clinical Translation of Nanomedicine. Chem. Rev. 2015, 115 (19), 11147–11190. 10.1021/acs.chemrev.5b00116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jain P. K.; Huang X.; El-Sayed I. H.; El-Sayed M. A. Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine. Acc. Chem. Res. 2008, 41 (12), 1578–1586. 10.1021/ar7002804. [DOI] [PubMed] [Google Scholar]
- Lacombe S.; Porcel E.; Scifoni E. Particle therapy and nanomedicine: state of art and research perspectives. Cancer Nanotechnology 2017, 8 (1), 9. 10.1186/s12645-017-0029-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maggiorella L.; Barouch G.; Devaux C.; Pottier A. e. s.; Deutsch E.; Bourhis J.; Borghi E.; Levy L. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncology 2012, 8 (9), 1167–1181. 10.2217/fon.12.96. [DOI] [PubMed] [Google Scholar]
- Wang W.; Zhang M.; Pan Z.; Biesold G. M.; Liang S.; Rao H.; Lin Z.; Zhong X. Colloidal Inorganic Ligand-Capped Nanocrystals: Fundamentals, Status, and Insights into Advanced Functional Nanodevices. Chem. Rev. 2022, 122, 4091–4162. 10.1021/acs.chemrev.1c00478. [DOI] [PubMed] [Google Scholar]
- Kister T.; Monego D.; Mulvaney P.; Widmer-Cooper A.; Kraus T. Colloidal Stability of Apolar Nanoparticles: The Role of Particle Size and Ligand Shell Structure. ACS Nano 2018, 12 (6), 5969–5977. 10.1021/acsnano.8b02202. [DOI] [PubMed] [Google Scholar]
- Zhang Y.-N.; Poon W.; Tavares A. J.; McGilvray I. D.; Chan W. C. W. Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination. J. Controlled Release 2016, 240, 332–348. 10.1016/j.jconrel.2016.01.020. [DOI] [PubMed] [Google Scholar]
- Nel A. E.; Mädler L.; Velegol D.; Xia T.; Hoek E. M. V.; Somasundaran P.; Klaessig F.; Castranova V.; Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8, 543. 10.1038/nmat2442. [DOI] [PubMed] [Google Scholar]
- Mahmoud K. A.; Mena J. A.; Male K. B.; Hrapovic S.; Kamen A.; Luong J. H. T. Effect of Surface Charge on the Cellular Uptake and Cytotoxicity of Fluorescent Labeled Cellulose Nanocrystals. ACS Appl. Mater. Interfaces 2010, 2 (10), 2924–2932. 10.1021/am1006222. [DOI] [PubMed] [Google Scholar]
- Knop K.; Hoogenboom R.; Fischer D.; Schubert U. S. Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angew. Chem., Int. Ed. 2010, 49 (36), 6288–6308. 10.1002/anie.200902672. [DOI] [PubMed] [Google Scholar]
- Suk J. S.; Xu Q.; Kim N.; Hanes J.; Ensign L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Delivery Rev. 2016, 99, 28–51. 10.1016/j.addr.2015.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landsiedel R.; Ma-Hock L.; Kroll A.; Hahn D.; Schnekenburger J.; Wiench K.; Wohlleben W. Testing Metal-Oxide Nanomaterials for Human Safety. Adv. Mater. 2010, 22 (24), 2601–2627. 10.1002/adma.200902658. [DOI] [PubMed] [Google Scholar]
- Soo Choi H.; Liu W.; Misra P.; Tanaka E.; Zimmer J. P; Itty Ipe B.; Bawendi M. G; Frangioni J. V Renal Clearance of Nanoparticles. Nature biotechnology 2007, 25 (10), 1165–1170. 10.1038/nbt1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jahanban-Esfahlan R.; Seidi K.; Banimohamad-Shotorbani B.; Jahanban-Esfahlan A.; Yousefi B. Combination of nanotechnology with vascular targeting agents for effective cancer therapy. Journal of Cellular Physiology 2018, 233 (4), 2982–2992. 10.1002/jcp.26051. [DOI] [PubMed] [Google Scholar]
- Bahrami B.; Hojjat-Farsangi M.; Mohammadi H.; Anvari E.; Ghalamfarsa G.; Yousefi M.; Jadidi-Niaragh F. Nanoparticles and targeted drug delivery in cancer therapy. Immunol. Lett. 2017, 190, 64–83. 10.1016/j.imlet.2017.07.015. [DOI] [PubMed] [Google Scholar]
- Wang H.; Wang R.; Cai K.; He H.; Liu Y.; Yen J.; Wang Z.; Xu M.; Sun Y.; Zhou X.; Yin Q.; Tang L.; Dobrucki I. T.; Dobrucki L. W.; Chaney E. J.; Boppart S. A.; Fan T. M.; Lezmi S. e. p.; Chen X.; Yin L.; Cheng J. Selective in vivo metabolic cell-labeling-mediated cancer targeting. Nat. Chem. Biol. 2017, 13, 415. 10.1038/nchembio.2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu X.; Yu M.; Kim H.; Mameli M.; Stellacci F. Determination of monolayer-protected gold nanoparticle ligand–shell morphology using NMR. Nature. Communications 2012, 3 (1), 1182. 10.1038/ncomms2155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Roo J.; Justo Y.; De Keukeleere K.; Van den Broeck F.; Martins J. C.; Van Driessche I.; Hens Z. Carboxylic-Acid-Passivated Metal Oxide Nanocrystals: Ligand Exchange Characteristics of a New Binding Motif. Angew. Chem., Int. Ed. 2015, 54 (22), 6488–6491. 10.1002/anie.201500965. [DOI] [PubMed] [Google Scholar]
- De Roo J.; Van den Broeck F.; De Keukeleere K.; Martins J. C.; Van Driessche I.; Hens Z. Unravelling the Surface Chemistry of Metal Oxide Nanocrystals, the Role of Acids and Bases. J. Am. Chem. Soc. 2014, 136 (27), 9650–9657. 10.1021/ja5032979. [DOI] [PubMed] [Google Scholar]
- De Roo J.; Van Driessche I.; Martins J. C.; Hens Z. Colloidal metal oxide nanocrystal catalysis by sustained chemically driven ligand displacement. Nat. Mater. 2016, 15 (5), 517–521. 10.1038/nmat4554. [DOI] [PubMed] [Google Scholar]
- De Roo J.; De Keukeleere K.; Hens Z.; Van Driessche I. From ligands to binding motifs and beyond; the enhanced versatility of nanocrystal surfaces. Dalton Transactions 2016, 45 (34), 13277–13283. 10.1039/C6DT02410F. [DOI] [PubMed] [Google Scholar]
- De Roo J.; Zhou Z.; Wang J.; Deblock L.; Crosby A. J.; Owen J. S.; Nonnenmann S. S. Synthesis of Phosphonic Acid Ligands for Nanocrystal Surface Functionalization and Solution Processed Memristors. Chem. Mater. 2018, 30 (21), 8034–8039. 10.1021/acs.chemmater.8b03768. [DOI] [Google Scholar]
- Paniagua S. A.; Giordano A. J.; Smith O. L.; Barlow S.; Li H.; Armstrong N. R.; Pemberton J. E.; Brédas J. L.; Ginger D.; Marder S. R. Phosphonic Acids for Interfacial Engineering of Transparent Conductive Oxides. Chem. Rev. 2016, 116 (12), 7117–58. 10.1021/acs.chemrev.6b00061. [DOI] [PubMed] [Google Scholar]
- Yamashita S.; Sudo T.; Kamiya H.; Okada Y. Ligand Exchange Reactions between Phosphonic Acids at TiO2 Nanoparticle Surfaces. ChemistrySelect 2021, 6 (12), 2923–2927. 10.1002/slct.202100541. [DOI] [Google Scholar]
- Schechtel E.; Dören R.; Frerichs H.; Panthöfer M.; Mondeshki M.; Tremel W. Mixed Ligand Shell Formation upon Catechol Ligand Adsorption on Hydrophobic TiO2 Nanoparticles. Langmuir 2019, 35 (38), 12518–12531. 10.1021/acs.langmuir.9b02496. [DOI] [PubMed] [Google Scholar]
- Cheng C.; Wen Y.; Xu X.; Gu H. Tunable synthesis of carboxyl-functionalized magnetite nanocrystal clusters with uniform size. J. Mater. Chem. 2009, 19 (46), 8782–8788. 10.1039/b910832g. [DOI] [Google Scholar]
- Gao J.; Ran X.; Shi C.; Cheng H.; Cheng T.; Su Y. One-step solvothermal synthesis of highly water-soluble, negatively charged superparamagnetic Fe3O4 colloidal nanocrystal clusters. Nanoscale 2013, 5 (15), 7026–7033. 10.1039/c3nr00931a. [DOI] [PubMed] [Google Scholar]
- Ge J.; Hu Y.; Biasini M.; Dong C.; Guo J.; Beyermann W. P.; Yin Y. One-Step Synthesis of Highly Water-Soluble Magnetite Colloidal Nanocrystals. Chem.—Eur. J. 2007, 13 (25), 7153–7161. 10.1002/chem.200700375. [DOI] [PubMed] [Google Scholar]
- Park J. Y.; Baek M. J.; Choi E. S.; Woo S.; Kim J. H.; Kim T. J.; Jung J. C.; Chae K. S.; Chang Y.; Lee G. H. Paramagnetic Ultrasmall Gadolinium Oxide Nanoparticles as Advanced T1MRI Contrast Agent: Account for Large Longitudinal Relaxivity, Optimal Particle Diameter, and In Vivo T1MR Images. ACS Nano 2009, 3 (11), 3663–3669. 10.1021/nn900761s. [DOI] [PubMed] [Google Scholar]
- Villa I.; Villa C.; Monguzzi A.; Babin V.; Tervoort E.; Nikl M.; Niederberger M.; Torrente Y.; Vedda A.; Lauria A. Demonstration of cellular imaging by using luminescent and anti-cytotoxic europium-doped hafnia nanocrystals. Nanoscale 2018, 10 (17), 7933–7940. 10.1039/C8NR00724A. [DOI] [PubMed] [Google Scholar]
- Palui G.; Aldeek F.; Wang W.; Mattoussi H. Strategies for interfacing inorganic nanocrystals with biological systems based on polymer-coating. Chem. Soc. Rev. 2015, 44 (1), 193–227. 10.1039/C4CS00124A. [DOI] [PubMed] [Google Scholar]
- Wang W.; Mattoussi H. Engineering the Bio-Nano Interface Using a Multifunctional Coordinating Polymer Coating. Acc. Chem. Res. 2020, 53 (6), 1124–1138. 10.1021/acs.accounts.9b00641. [DOI] [PubMed] [Google Scholar]
- Plan Sangnier A.; Van de Walle A. B.; Curcio A.; Le Borgne R.; Motte L.; Lalatonne Y.; Wilhelm C. Impact of magnetic nanoparticle surface coating on their long-term intracellular biodegradation in stem cells. Nanoscale 2019, 11 (35), 16488–16498. 10.1039/C9NR05624F. [DOI] [PubMed] [Google Scholar]
- Guénin E.; Lalatonne Y.; Bolley J.; Milosevic I.; Platas-Iglesias C.; Motte L. Catechol versus bisphosphonate ligand exchange at the surface of iron oxide nanoparticles: towards multi-functionalization. J. Nanopart. Res. 2014, 16 (11), 2596. 10.1007/s11051-014-2596-7. [DOI] [Google Scholar]
- Zeininger L.; Portilla L.; Halik M.; Hirsch A. Quantitative Determination and Comparison of the Surface Binding of Phosphonic Acid, Carboxylic Acid, and Catechol Ligands on TiO2 Nanoparticles. Chem.—Eur. J. 2016, 22 (38), 13506–13512. 10.1002/chem.201601920. [DOI] [PubMed] [Google Scholar]
- Okada Y.; Asama H.; Koike N.; Yamashita S.; Maeta N.; Uesaka A.; Kamiya H. Direct Ordering of Anchoring Events at the Surface of Iron Oxide Nanoparticles Enabled by A Stepwise Phase-Transfer Strategy. ChemistrySelect 2018, 3 (29), 8458–8461. 10.1002/slct.201801416. [DOI] [Google Scholar]
- Hens Z.; Martins J. C. A Solution NMR Toolbox for Characterizing the Surface Chemistry of Colloidal Nanocrystals. Chem. Mater. 2013, 25 (8), 1211–1221. 10.1021/cm303361s. [DOI] [Google Scholar]
- Hartley C. L.; Kessler M. L.; Dempsey J. L. Molecular-Level Insight into Semiconductor Nanocrystal Surfaces. J. Am. Chem. Soc. 2021, 143 (3), 1251–1266. 10.1021/jacs.0c10658. [DOI] [PubMed] [Google Scholar]
- Jayawardena H. S. N.; Liyanage S. H.; Rathnayake K.; Patel U.; Yan M. Analytical Methods for Characterization of Nanomaterial Surfaces. Anal. Chem. 2021, 93 (4), 1889–1911. 10.1021/acs.analchem.0c05208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marbella L. E.; Millstone J. E. NMR Techniques for Noble Metal Nanoparticles. Chem. Mater. 2015, 27 (8), 2721–2739. 10.1021/cm504809c. [DOI] [Google Scholar]
- De Roo J.; Yazdani N.; Drijvers E.; Lauria A.; Maes J.; Owen J. S.; Van Driessche I.; Niederberger M.; Wood V.; Martins J. C.; Infante I.; Hens Z. Probing Solvent–Ligand Interactions in Colloidal Nanocrystals by the NMR Line Broadening. Chem. Mater. 2018, 30 (15), 5485–5492. 10.1021/acs.chemmater.8b02523. [DOI] [Google Scholar]
- Chen Y.; Dorn R. W.; Hanrahan M. P.; Wei L.; Blome-Fernández R.; Medina-Gonzalez A. M.; Adamson M. A. S.; Flintgruber A. H.; Vela J.; Rossini A. J. Revealing the Surface Structure of CdSe Nanocrystals by Dynamic Nuclear Polarization-Enhanced 77Se and 113Cd Solid-State NMR Spectroscopy. J. Am. Chem. Soc. 2021, 143 (23), 8747–8760. 10.1021/jacs.1c03162. [DOI] [PubMed] [Google Scholar]
- Lauria A.; Villa I.; Fasoli M.; Niederberger M.; Vedda A. Multifunctional Role of Rare Earth Doping in Optical Materials: Nonaqueous Sol-Gel Synthesis of Stabilized Cubic HfO2 Luminescent Nanoparticles. ACS Nano 2013, 7 (8), 7041–7052. 10.1021/nn402357s. [DOI] [PubMed] [Google Scholar]
- Stejskal E. O.; Tanner J. E. Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient. J. Chem. Phys. 1965, 42 (1), 288–292. 10.1063/1.1695690. [DOI] [Google Scholar]
- Zito J.; Infante I. The Future of Ligand Engineering in Colloidal Semiconductor Nanocrystals. Acc. Chem. Res. 2021, 54 (7), 1555–1564. 10.1021/acs.accounts.0c00765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drijvers E.; De Roo J.; Martins J. C.; Infante I.; Hens Z. Ligand Displacement Exposes Binding Site Heterogeneity on CdSe Nanocrystal Surfaces. Chem. Mater. 2018, 30 (3), 1178–1186. 10.1021/acs.chemmater.7b05362. [DOI] [Google Scholar]
- Knauf R. R.; Lennox J. C.; Dempsey J. L. Quantifying Ligand Exchange Reactions at CdSe Nanocrystal Surfaces. Chem. Mater. 2016, 28 (13), 4762–4770. 10.1021/acs.chemmater.6b01827. [DOI] [Google Scholar]
- Gomes R.; Hassinen A.; Szczygiel A.; Zhao Q. A.; Vantomme A.; Martins J. C.; Hens Z. Binding of Phosphonic Acids to CdSe Quantum Dots: A Solution NMR Study. J. Phys. Chem. Lett. 2011, 2 (3), 145–152. 10.1021/jz1016729. [DOI] [Google Scholar]
- Amstad E.; Gillich T.; Bilecka I.; Textor M.; Reimhult E. Ultrastable Iron Oxide Nanoparticle Colloidal Suspensions Using Dispersants with Catechol-Derived Anchor Groups. Nano Lett. 2009, 9 (12), 4042–4048. 10.1021/nl902212q. [DOI] [PubMed] [Google Scholar]
- Napolitano A.; d’Ischia M.; Costantini C.; Prota G. A new oxidation pathway of the neurotoxin 6-aminodopamine. Isolation and characterisation of a dimer with a tetrahydro[3,4a]iminoethanophenoxazine ring system. Tetrahedron 1992, 48 (39), 8515–8522. 10.1016/S0040-4020(01)86599-6. [DOI] [Google Scholar]
- Meißler M.; Taden A.; Börner H. G. Enzyme-Triggered Antifouling Coatings: Switching Bioconjugate Adsorption via Proteolytically Cleavable Interfering Domains. ACS Macro Lett. 2016, 5 (5), 583–587. 10.1021/acsmacrolett.6b00072. [DOI] [PubMed] [Google Scholar]
- Dragoman R. M.; Grogg M.; Bodnarchuk M. I.; Tiefenboeck P.; Hilvert D.; Dirin D. N.; Kovalenko M. V. Surface-Engineered Cationic Nanocrystals Stable in Biological Buffers and High Ionic Strength Solutions. Chem. Mater. 2017, 29 (21), 9416–9428. 10.1021/acs.chemmater.7b03504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amstad E.; Gehring A. U.; Fischer H.; Nagaiyanallur V. V.; Hähner G.; Textor M.; Reimhult E. Influence of Electronegative Substituents on the Binding Affinity of Catechol-Derived Anchors to Fe3O4 Nanoparticles. J. Phys. Chem. C 2011, 115 (3), 683–691. 10.1021/jp1109306. [DOI] [Google Scholar]
- Gillich T.; Benetti E. M.; Rakhmatullina E.; Konradi R.; Li W.; Zhang A.; Schlüter A. D.; Textor M. Self-Assembly of Focal Point Oligo-catechol Ethylene Glycol Dendrons on Titanium Oxide Surfaces: Adsorption Kinetics, Surface Characterization, and Nonfouling Properties. J. Am. Chem. Soc. 2011, 133 (28), 10940–10950. 10.1021/ja202760x. [DOI] [PubMed] [Google Scholar]
- Xie J.; Xu C.; Kohler N.; Hou Y.; Sun S. Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non-Specific Uptake by Macrophage Cells. Adv. Mater. 2007, 19 (20), 3163–3166. 10.1002/adma.200701975. [DOI] [Google Scholar]
- Bae K. H.; Kim Y. B.; Lee Y.; Hwang J.; Park H.; Park T. G. Bioinspired Synthesis and Characterization of Gadolinium-Labeled Magnetite Nanoparticles for Dual Contrast T1- and T2-Weighted Magnetic Resonance Imaging. Bioconjugate Chem. 2010, 21 (3), 505–512. 10.1021/bc900424u. [DOI] [PubMed] [Google Scholar]
- Kamimura M.; Kanayama N.; Tokuzen K.; Soga K.; Nagasaki Y. Near-infrared (1550 nm) in vivo bioimaging based on rare-earth doped ceramic nanophosphors modified with PEG-b-poly(4-vinylbenzylphosphonate). Nanoscale 2011, 3 (9), 3705–3713. 10.1039/c1nr10466g. [DOI] [PubMed] [Google Scholar]
- Traina C. A.; Schwartz J. Surface Modification of Y2O3 Nanoparticles. Langmuir 2007, 23 (18), 9158–9161. 10.1021/la701653v. [DOI] [PubMed] [Google Scholar]
- Lam T.; Avti P. K.; Pouliot P.; Tardif J.-C.; Rhéaume É.; Lesage F.; Kakkar A. Surface engineering of SPIONs: role of phosphonate ligand multivalency in tailoring their efficacy. Nanotechnology 2016, 27 (41), 415602. 10.1088/0957-4484/27/41/415602. [DOI] [PubMed] [Google Scholar]
- Patsula V.; Kosinová L.; Lovrić M.; Ferhatovic Hamzić L.; Rabyk M.; Konefal R.; Paruzel A.; Šlouf M.; Herynek V.; Gajović S.; Horák D. Superparamagnetic Fe3O4 Nanoparticles: Synthesis by Thermal Decomposition of Iron(III) Glucuronate and Application in Magnetic Resonance Imaging. ACS Appl. Mater. Interfaces 2016, 8 (11), 7238–7247. 10.1021/acsami.5b12720. [DOI] [PubMed] [Google Scholar]
- Das M.; Mishra D.; Dhak P.; Gupta S.; Maiti T. K.; Basak A.; Pramanik P. Biofunctionalized, Phosphonate-Grafted, Ultrasmall Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Multimodal Imaging. Small 2009, 5 (24), 2883–2893. 10.1002/smll.200901219. [DOI] [PubMed] [Google Scholar]
- Grisorio R.; Debellis D.; Suranna G. P.; Gigli G.; Giansante C. The Dynamic Organic/Inorganic Interface of Colloidal PbS Quantum Dots. Angewandte Chemie (International ed. in English) 2016, 55 (23), 6628–33. 10.1002/anie.201511174. [DOI] [PubMed] [Google Scholar]
- De Roo J.; De Keukeleere K.; Feys J.; Lommens P.; Hens Z.; Van Driessche I. Fast, microwave-assisted synthesis of monodisperse HfO2 nanoparticles. J. Nanopart. Res. 2013, 15 (7), 1778. 10.1007/s11051-013-1778-z. [DOI] [Google Scholar]
- Esarey S. L.; Bartlett B. M. pH-Dependence of Binding Constants and Desorption Rates of Phosphonate- and Hydroxamate-Anchored [Ru(bpy)3]2+ on TiO2 and WO3. Langmuir 2018, 34 (15), 4535–4547. 10.1021/acs.langmuir.8b00263. [DOI] [PubMed] [Google Scholar]
- Yu J.; Wei W.; Menyo M. S.; Masic A.; Waite J. H.; Israelachvili J. N. Adhesion of Mussel Foot Protein-3 to TiO2 Surfaces: the Effect of pH. Biomacromolecules 2013, 14 (4), 1072–1077. 10.1021/bm301908y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cencer M.; Murley M.; Liu Y.; Lee B. P. Effect of Nitro-Functionalization on the Cross-Linking and Bioadhesion of Biomimetic Adhesive Moiety. Biomacromolecules 2015, 16 (1), 404–410. 10.1021/bm5016333. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.